A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma.

Patients who achieved favorable pathological responses (Grade 0, 1) to preoperative chemoradiotehrapy had relatively higher overall survival as compared to those achieving unfavorable responses, however, the difference did not reach statistical significance.

also in 111,027 other papers